Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Intrexon reported $46.73M in Current Liabilities for its fiscal quarter ending in March of 2023.

Current Liabilities Change
Agenus AGEN:US USD 190.9M 1.95M
Alaunos Therapeutics Inc ZIOP:US USD 17.06M 7.1M
Amgen AMGN:US USD 14.22B 1.47B
Anika Therapeutics ANIK:US USD 28.69M 779K
Arrowhead Research ARWR:US USD 87.15M 34.86M
AstraZeneca AZN:LN USD 24.86B 1.43B
Bluebird Bio BLUE:US USD 115.93M 12.3M
Gilead Sciences GILD:US USD 10.53B 709M
GlaxoSmithKline GSK:LN GBP 20.7B 2.11B
Heron Therapeutics HRTX:US USD 77.9M 4.46M
Immunogen IMGN:US USD 101.63M 20.23M
Incyte Corp INCY:US USD 1.01B 150.97M
Intrexon XON:US USD 46.73M 31.91M
Karyopharm Therapeutics KPTI:US USD 61.56M 10.45M
Ligand Pharmaceuticals LGND:US USD 98.93M 119K
MacroGenics MGNX:US USD 45.61M 3M
MannKind MNKD:US USD 81.85M 14.56M
Novartis NOVN:VX USD 30.55B 1.89B
Peregrine Pharmaceuticals PPHM:US USD 87.32M 4.94M
Rigel Pharmaceuticals RIGL:US USD 45.52M 19.69M
Roche Holding ROG:VX CHF 27.24B 170M
Sangamo BioSciences SGMO:US USD 57.84M 53.87M
Thermo Fisher Scientific TMO:US USD 15.88B 1.23B
Veracyte VCYT:US USD 55.99M 6.62M
Xencor XNCR:US USD 65.06M 1.21M